课题基金 / 基金详情

项目摘要

项目成果

Zvonimir S Katusic的其他基金

相似基金

相关文献

中文摘要
翻译
内皮功能障碍定义为内皮细胞产生的生物活性一氧化氮(NO)的丧失,
英文摘要
Endothelial dysfunction defined as a loss of biologically active nitric oxide (NO) produced in the endothelium, is one of the most important events in initiation and progression of vascular disease. Tetrahydrobiopterin (BH4) is an essential cofactor needed for enzymatic activity of nitric oxide synthase(s) and biosynthesis of NO. In vivo mechanisms responsible for the control of BH4 metabolism are poorly understood. During preliminary studies for this application we identified erythropoietin (EPO) as a novel and potent stimulator of BH4 biosynthesis in the cardiovascular system. EPO is circulating hormone responsible for control of erythropoiesis, however, more recent findings suggest that EPO has important non-erythropoietic effects including vascular protection. The general hypothesis of this proposal is that in vivo, BH4 critically contributes to the vascular protective effect of EPO. To test this hypothesis we propose studies with following specific aims: 1) determine the role of BH4 in mediation of protective effectsof EPO in vascular endothelium, 2) determine if EPO may prevent development of atherosclerosis, and 3) analyze the mechanisms of EPO- induced endothelial repair after vascular injury. In vivo genetic and pharmacological approaches will be used to manipulate levels of circulating EPO and BH4. Established murine models of endothelial dysfunction and vascular injury will be employed to determine role of BH4 in mediation of vascular protective effects of EPO. To dissect direct effects of EPO from its rheological effects due to increase in shear stress imposed on endothelium by circulating erythrocytes, effects of novel non-erythropoietic derivatives of EPO will be studied. It is anticipated that the results of the proposed experiments will provide novel and important information concerning the role of EPO in control of BH4 metabolism in the cardiovascular system. This information may help to develop new strategies in prevention and treatment of endothelial dysfunction. .
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
Guanosine triphosphate cyclohydrolase I expression and enzymatic activity are present in caveolae of endothelial cells.
三磷酸鸟苷环水解酶 I 表达和酶活性存在于内皮细胞的小窝中。
DOI: 10.1161/hypertensionaha.108.115709
发表时间: 2009
期刊: Hypertension (Dallas, Tex. : 1979)
影响因子: --
作者: [Peterson,TimothyE, d'Uscio,LiviusV, Cao,Sheng, Wang,Xiao-Li, Katusic,ZvonimirS]
通讯作者: Katusic,ZvonimirS
DOI: 10.3171/jns.1998.89.1.0111
发表时间: 1998-07
期刊: Journal of neurosurgery
影响因子: 4.1
作者: [Hisashi Onoue;Z. Katusic]
通讯作者: Hisashi Onoue;Z. Katusic
DOI: 10.1161/hypertensionaha.111.172189
发表时间: 2011-08
期刊: Hypertension (Dallas, Tex. : 1979)
影响因子: --
作者: [He T, Smith LA, Lu T, Joyner MJ, Katusic ZS]
通讯作者: Katusic ZS
DOI: 10.1016/j.tips.2008.10.003
发表时间: 2009-01
期刊: TRENDS IN PHARMACOLOGICAL SCIENCES
影响因子: 13.8
作者: [Katusic, Zvonimir S., d'Uscio, Livius V., Nath, Karl A.]
通讯作者: Nath, Karl A.
共 10 条
    Role of endothelium in pathogenesis of cerebral amyloid angiopathy
    • 批准号:
      10311153
    • 项目类别:
    • 资助金额:
      $65.45万
    • 财政年份:
      2021
    • 负责人:
      Zvonimir S Katusic
    • 依托单位:
    Role of endothelium in pathogenesis of cerebral amyloid angiopathy
    • 批准号:
      10478114
    • 项目类别:
    • 资助金额:
      $65.41万
    • 财政年份:
      2021
    • 负责人:
      Zvonimir S Katusic
    • 依托单位:
    Role of endothelium in pathogenesis of cerebral amyloid angiopathy
    • 批准号:
      10624872
    • 项目类别:
    • 资助金额:
      $64.8万
    • 财政年份:
      2021
    • 负责人:
      Zvonimir S Katusic
    • 依托单位:
    Endothelial dysfunction in the cerebral circulation
    • 批准号:
      8403744
    • 项目类别:
    • 资助金额:
      $42.99万
    • 财政年份:
      2012
    • 负责人:
      Zvonimir S Katusic
    • 依托单位:
    海外基金